Australia's Somnomed hits 32-month high on upbeat revenue growth
30/10/2025 04:17
** Shares of Somnomed SOM.AX rise as much as 9.9% to A$0.945, their highest level since February 13, 2023 ** Stock posts biggest intraday pct rise since October 20 ** Medical device maker reports first-quarter revenue of A$28.7 million ($18.65 million), up 13.5% vs pcp ** Stock up 90.2% YTD, including the session's moves ($1 = 1.5389 Australian dollars) (Reporting by Anjali Singh in Bengaluru) ((anjali.singh2@thomsonreuters.com; ))
Recent news on SomnoMed
See all newsAustralia's Somnomed jumps most in 7 months on strong half-year earnings
Brief: Somnomed® Increases Investment In Managed Care Infrastructure
Australia's Somnomed hits 32-month high on upbeat revenue growth
Brief: Somnomed Says Q1 FY26 Revenue Up 13.5% To A$28.7 Million
Brief: Somnomed Says FY EBITDA AUD 9.2 Million